Sofinnova
Highly Engaged Employees
Highly Engaged EmployeesFinance · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3000 Sand Hill Rd Bldg 4 Ste 250, Menlo ...Phone Number
(650) 681-8420Website
www.sofinnova.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
2
2
2
1
About Sofinnova
Sofinnova is a clinical-stage biopharmaceutical venture capital firm that manages approximately $2B in assets and committed capital. The company partners with world-class entrepreneurs to transform innovative ideas into viable drugs, guiding them through drug development, regulatory processes, and company building. With a strong track record of funding 118 companies, achieving 55 IPOs, and 33 FDA drug approvals, Sofinnova is dedicated to advancing medical care and improving lives. Their mission is to provide not just capital, but also the necessary tools and expertise to help innovators succeed in the biopharmaceutical industry.Explore more
Sofinnova Org Chart
JB
Chief Compliance Officer & Chief Operating Of...
CC
Executive Partner, Private Equity
HS
Chief Legal Officer & Partner
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sofinnova your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Sofinnova, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Sofinnova has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Sofinnova has new funding data
Product Launch: Get notified when Sofinnova launches new products
Website visits: Recent activity has been detected on your website
Click to see if Sofinnova had a recent Job posting/layoffs
Check out if Sofinnova is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Sofinnova
Earning: See what the market has to say on Sofinnova recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Sofinnova
Compare insights from companies similar to Sofinnova, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sofinnova is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Sofinnova is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Sofinnova.
Sofinnova Tech Stack
A closer look at the technologies used by Sofinnova
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Award
Award, Spending/Investment, Finance, Operations
Project
Spending/Investment
Sofinnova News & Media
Sofinnova Partners secures €650M to back breakthroughs in biopharma and medical technology
Life sciences venture capital firm Sofinnova Partners today announced the close of its latest flagship fund, Sofinnova Capital XI, at €650 million ($750 million), greatly exceeding its initial target....Sofinnova Partners appoints Karl Naegler as Partner
PARIS--(BUSINESS WIRE)--Sofinnova Partners (“Sofinnova"), a leading European venture capital firm in life sciences, based in Paris, London, and Milan, announced the appointment of Karl Naegler as Partner. This strategic hire also marks Sofinnova’s expansion into Germany, bolstering its reach and influence across Europe. Naegler will play a key role in Sofinnova Capital, the firm’s early-stage investment strategy, established 35 years ago. His expertise strengthens the firm’s commitment to champHEPTA Medical Secures €5.7 Million Series A, Led by BPI France to Advance Minimally Invasive Lung Cancer Treatment
SURESNES, France--(BUSINESS WIRE)--HEPTA Medical (“HEPTA”), a private medical device company dedicated to providing an efficient, safe, and minimally-invasive thermal ablation therapy for early-stage lung cancer, today announced it has successfully raised €5.7M in the first close of its Series A funding round. The investment was led by BPI France with the participation of M&L Healthcare and Clery IG. This financing round will enable HEPTA to initiate the US regulatory approval process for tBiogen CMO Maha Radhakrishnan joins Sofinnova—Chutes & Ladders - Fierce Biotech
Welcome to this week's Chutes & Ladders, our roundup | Former Biogen Chief Medical Officer Maha Radhakrishnan, M.D., is now an executive partner at healthcare investment firm Sofinnova Investments.
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Sofinnova
Sign Up For FreeTo access detailed company insights
Sofinnova is a clinical-stage biopharmaceutical venture capital firm that manages approximately $2B in assets and committed capital. The company partners with world-class entrepreneurs to transform innovative ideas into viable drugs, guiding them through drug development, regulatory processes, and company building. With a strong track record of fun... Read More
